Overall PGNY gets a fundamental rating of 7 out of 10. We evaluated PGNY against 103 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making PGNY a very profitable company, without any liquidiy or solvency issues. PGNY is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make PGNY suitable for growth and quality investing!

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

PGNY had positive earnings in the past year.
In the past year PGNY had a positive cash flow from operations.
In the past 5 years PGNY has always been profitable.
Each year in the past 5 years PGNY had a positive operating cash flow.

1.2 Ratios

With an excellent Return On Assets value of 7.11%, PGNY belongs to the best of the industry, outperforming 88.35% of the companies in the same industry.
The Return On Equity of PGNY (10.10%) is better than 71.84% of its industry peers.
With an excellent Return On Invested Capital value of 11.24%, PGNY belongs to the best of the industry, outperforming 83.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PGNY is in line with the industry average of 9.16%.
The last Return On Invested Capital (11.24%) for PGNY is above the 3 year average (8.25%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	7.11%
ROE	10.1%
ROIC	11.24%

ROA(3y)7.58%

ROA(5y)11.89%

ROE(3y)10.72%

ROE(5y)17.23%

ROIC(3y)8.25%

ROIC(5y)7.66%

1.3 Margins

With a decent Profit Margin value of 4.46%, PGNY is doing good in the industry, outperforming 77.67% of the companies in the same industry.
PGNY's Profit Margin has declined in the last couple of years.
PGNY has a better Operating Margin (6.77%) than 70.87% of its industry peers.
PGNY's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 22.94%, PGNY is in line with its industry, outperforming 48.54% of the companies in the same industry.
In the last couple of years the Gross Margin of PGNY has grown nicely.

		Industry Rank	Sector Rank
OM	6.77%
PM (TTM)	4.46%
GM	22.94%

OM growth 3Y-3.61%

OM growth 5Y1.87%

PM growth 3Y-29.25%

PM growth 5YN/A

GM growth 3Y-1.03%

GM growth 5Y1.85%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PGNY is still creating some value.
PGNY has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PGNY has more shares outstanding
There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

PGNY has an Altman-Z score of 8.21. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.21, PGNY belongs to the top of the industry, outperforming 94.17% of the companies in the same industry.
PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	8.21

ROIC/WACC1.27

WACC8.88%

2.3 Liquidity

PGNY has a Current Ratio of 2.96. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PGNY (2.96) is better than 83.50% of its industry peers.
PGNY has a Quick Ratio of 2.96. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.96, PGNY belongs to the best of the industry, outperforming 83.50% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.96
Quick Ratio	2.96

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PGNY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.62%, which is quite good.
Measured over the past years, PGNY shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.77% on average per year.
The Revenue has grown by 11.41% in the past year. This is quite good.
PGNY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.42% yearly.

EPS 1Y (TTM)8.62%

EPS 3Y-4.77%

EPS 5YN/A

EPS Q2Q%36.36%

Revenue 1Y (TTM)11.41%

Revenue growth 3Y32.6%

Revenue growth 5Y38.42%

Sales Q2Q%9.32%

3.2 Future

Based on estimates for the next years, PGNY will show a very strong growth in Earnings Per Share. The EPS will grow by 32.94% on average per year.
Based on estimates for the next years, PGNY will show a quite strong growth in Revenue. The Revenue will grow by 8.83% on average per year.

EPS Next Y17.75%

EPS Next 2Y29.28%

EPS Next 3Y26.74%

EPS Next 5Y32.94%

Revenue Next Year11.37%

Revenue Next 2Y10.44%

Revenue Next 3Y10.6%

Revenue Next 5Y8.83%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 37.89, which means the current valuation is very expensive for PGNY.
PGNY's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of PGNY to the average of the S&P500 Index (28.30), we can say PGNY is valued slightly more expensively.
A Price/Forward Earnings ratio of 25.06 indicates a quite expensive valuation of PGNY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PGNY is on the same level as its industry peers.
PGNY is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 25.57, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	37.89
Fwd PE	25.06

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PGNY is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, PGNY is valued cheaply inside the industry as 83.50% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	10.64
EV/EBITDA	16.87

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PGNY does not grow enough to justify the current Price/Earnings ratio.
PGNY has a very decent profitability rating, which may justify a higher PE ratio.
PGNY's earnings are expected to grow with 26.74% in the coming years. This may justify a more expensive valuation.